Lexicon Pharmaceuticals (LXRX) Net Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,435.00 |
| Dec 31, 2025 | -18,314.00 |
| Sep 30, 2025 | -9,888.00 |
| Jun 30, 2025 | 204,773.00 |
| Mar 31, 2025 | -191,150.00 |
| Dec 31, 2024 | 351,632.00 |
| Sep 30, 2024 | -27,870.00 |
| Jun 30, 2024 | 78,668.00 |
| Mar 31, 2024 | 195,386.00 |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | -1.85 Mn |
| Jun 30, 2021 | 7.01 Mn |
| Mar 31, 2021 | -7.78 Mn |
| Jun 30, 2020 | -27.80 Mn |
| Mar 31, 2020 | -25,874.00 |
| Dec 31, 2019 | -66,072.00 |
| Sep 30, 2019 | 31,962.00 |
| Jun 30, 2019 | 68,116.00 |
| Mar 31, 2019 | -82,772.00 |
| Dec 31, 2018 | 29,497.00 |
| Sep 30, 2018 | -14,175.00 |
| Jun 30, 2018 | -8,571.00 |
| Mar 31, 2018 | -8,830.00 |
| Dec 31, 2017 | 3,350.00 |
| Sep 30, 2017 | 17,904.00 |
| Jun 30, 2017 | -4,764.00 |
| Mar 31, 2017 | -14,503.00 |
| Jun 30, 2016 | 8,948.00 |
| Mar 31, 2016 | -34,730.00 |
| Dec 31, 2015 | 631,616.00 |
| Sep 30, 2015 | 128,998.00 |
| Jun 30, 2015 | -596,275.00 |
| Mar 31, 2015 | -155,508.00 |
| Dec 31, 2014 | 971,250.00 |
| Sep 30, 2014 | -580,341.00 |
| Jun 30, 2014 | 723,353.00 |
| Mar 31, 2014 | -992,650.00 |
| Dec 31, 2013 | 1.21 Mn |
| Sep 30, 2013 | 28,061.00 |
| Jun 30, 2013 | -636,247.00 |
| Mar 31, 2013 | 422,372.00 |
| Dec 31, 2012 | -350,650.00 |
| Sep 30, 2012 | 509,954.00 |
| Jun 30, 2012 | -308,654.00 |
| Mar 31, 2012 | -8,732.00 |
| Dec 31, 2011 | -251,439.00 |
| Sep 30, 2011 | -254,791.00 |
| Jun 30, 2011 | 17,079.00 |
| Mar 31, 2011 | -314,032.00 |
| Dec 31, 2010 | 168,728.00 |
| Sep 30, 2010 | -152,741.00 |